Shivom is a blockchain-based and genetic testing platform for storing, combining, and interrogating genomic datasets that launched in 2017 and was founded by Gourish Singla and Axel Schumacher. Notalbe customers using Shivom include: Nova, Qiagen, Deloitte, Institut Pasteur, The Francis Crick Institute, CNIO, Ku Leuven, Queen Mary University of London, and BSC.
Shivom users are able to control their genetic data by storing it privately, open-sourced, or monetized to have their data produce residual income for them. Each user can choose who gets permission to access their data and can safely upload sensitive data about their health. Users are able to access a genomic marketplace they can pay-per-use to access genomic data sets. The platform also allows bioinformatic teams to manage and collaborate anonymously on multi-omics projects made possible through Shivom with unlimited cloud storage. Shivom gives researchers the ability to perform genome-wide association studies, phenome wide association studies, polygenic risk scores, and meta-analysis of genome-wide association studies using colocalization, medelian randomization, and genetic correlation.
Timeline
People
Agam Kansal
Vice President of Marketing
Akash Gaurav
CTO
Dr. Natalie Pankova
CSO
Dr.Axel Schumacher
Co-Founder & CEO
Gourish Singla
Co-Founder & COO
Henry Ines
CIO
Project shivom
Founder
Sally Eaves
Co-Founder & CMO
Further reading
Blockchain can be the catalyst for a revolution in precision medicine
Shivom
Web
Shivom Partners With MeFy to Foster Healthcare Data Collection and Accessibility in Developing...
Shivom
Web
Shivom Partners With SingularityNET For Strengthening Genomics Medical Research and Advanced...
Shivom
Web
Documentaries, videos and podcasts
Disruptive Technologies for good | Sally Eaves | TEDxBirminghamCityUniversity
January 31, 2018
Project SHIVOM (Official Video) | Powering the Next Era of Genomics through Blockchain
February 27, 2018